Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Trypsin; duodenal fluid

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

Trypsin is a digestive enzyme classified as a serine protease, which is produced by the pancreas in an inactive form known as trypsinogen. This inactive precursor is secreted into the duodenum through the pancreatic duct, where it is activated into trypsin by the enzyme enteropeptidase. The primary function of trypsin is to hydrolyze ingested proteins into smaller peptides and amino acids, facilitating their absorption and digestion in the gastrointestinal tract. The measurement of trypsin levels in duodenal fluid serves as an important diagnostic tool for assessing pancreatic function. Abnormal levels of trypsin can indicate various pancreatic disorders. For instance, severely reduced levels of trypsin in duodenal fluid are often associated with chronic pancreatitis and carcinoma of the head of the pancreas. In contrast, less severely reduced levels may be observed in conditions such as diabetic glucose intolerance and obstruction of the common bile duct. This test is crucial for clinicians to evaluate pancreatic health and diagnose potential pathologies related to pancreatic enzyme production.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

Measurement of trypsin levels in duodenal fluid is indicated for the evaluation of pancreatic function in various clinical scenarios.

  • Chronic Pancreatitis Severely reduced trypsin levels in duodenal fluid can indicate the presence of chronic pancreatitis, a condition characterized by long-term inflammation of the pancreas.
  • Carcinoma of the Head of the Pancreas The presence of carcinoma in the head of the pancreas may also lead to significantly decreased trypsin levels, suggesting impaired pancreatic function.
  • Diabetic Glucose Intolerance Less severely reduced trypsin levels may be observed in patients with diabetic glucose intolerance, indicating potential pancreatic dysfunction.
  • Obstruction of the Common Bile Duct Obstruction in the common bile duct can also result in decreased trypsin levels, reflecting an underlying issue with pancreatic enzyme secretion.

2. Procedure

The procedure for measuring trypsin levels in duodenal fluid involves several key steps to ensure accurate results.

  • Step 1: Sample Collection The first step involves the collection of duodenal fluid, which is typically obtained through a duodenal aspirate. This is performed by passing a tube through the nose or mouth into the stomach and then into the duodenum, allowing for the collection of the fluid that contains digestive enzymes, including trypsin.
  • Step 2: Sample Preparation Once the duodenal fluid is collected, it must be properly prepared for analysis. This may involve centrifugation to separate the fluid from any particulate matter, ensuring that the sample is suitable for testing.
  • Step 3: Trypsin Measurement The prepared sample is then subjected to a biochemical assay specifically designed to measure the concentration of trypsin. This assay may utilize various methods, such as immunoassays or enzymatic assays, to quantify the levels of trypsin present in the fluid.
  • Step 4: Result Interpretation After the measurement is completed, the results are interpreted in the context of the patient's clinical condition. Significantly low levels of trypsin may indicate pancreatic insufficiency or other related disorders, while normal levels suggest adequate pancreatic function.

3. Post-Procedure

Post-procedure care primarily involves monitoring the patient for any potential complications related to the duodenal aspirate procedure, such as discomfort or bleeding. Patients may be advised to resume normal activities shortly after the procedure, as it is generally well-tolerated. The results of the trypsin measurement will be discussed with the patient in a follow-up appointment, where further diagnostic steps or treatment options may be considered based on the findings. It is essential for healthcare providers to ensure that patients understand the implications of their test results and any necessary follow-up actions.

Short Descr ASSAY DUODENAL FLUID TRYPSIN
Medium Descr ASSAY OF TRYPSIN DUODENAL FLUID
Long Descr Trypsin; duodenal fluid
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
CLIA Waived (QW) No
APC Status Indicator Conditionally packaged laboratory tests
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE 1
CCS Clinical Classification 233 - Laboratory - Chemistry and Hematology
Date
Action
Notes
2013-01-01 Changed Medium Descriptor changed.
Pre-1990 Added Code added.
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"